Research
Menstruation and Lupus
Because changing hormone levels effect the immune system in a big way,...
Antimalarial Drugs and Lupus
Antimalarial drugs are medications that were originally used to treat malaria. But,...
Women and Lupus: The Impact of Genetics & Hormones
Genetics and hormones both contribute to the development of autoimmune diseases. And, women are nine times more likely than men to be battling autoimmune diseases like lupus. Autoimmune diseases are a broad collection of over 100 diseases characterized by autoimmunity -- a condition where the body's immune...
Direct-To-Family (Decentralized) Clinical Trials
Direct-to-family -- also known as decentralized or remote -- clinical trials could open the doors for new treatments and understanding of lupus. One of the main hurdles to lupus drug development is getting enough people for a clinical trial. Clinical trials assess the effectiveness...
What is Autoimmune Hypophysitis?
Autoimmune hypophysitis is a chronic inflammation of the pituitary gland that can happen alongside autoimmune diseases like lupus. It leads to a host of additional symptoms. Autoimmune hypophysitis (AH or lymphocytic hypophysotis) is chronic inflammation of the pituitary gland. This causes the gland to...
Platelet Counts, Thrombocytopenia, and Lupus
Lupus can have far reaching impacts throughout the body. Low platelet count, also known as thrombocytopenia, is a common symptom. Platelets are cells in the bloodstream that clump together on injury to prevent bleeding. Platelets are produced in the bone marrow and are found throughout the...
AI, Machine-Based Learning Software, and Lupus
Will artificial intelligence help us better understand lupus? The answer is yes, through the process of machine learning. (Powered by the correct data of course) “Machine learning” is a term for a type of artificial intelligence or “AI” that adapts and changes how it...
FDA Approves Aurinia Pharmaceuticals’ LUPKYNIS for Adult Patients with Active Lupus Nephritis
LUPKYNIS (voclosporin) is the first FDA-approved oral therapy for lupus nephritis, a condition that causes irreversible kidney damage and increases the risk of kidney failure, cardiac events, and death. On Monday, January 25, 2021, Aurinia Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) approved LUPKYNIS (voclosporin) to...
Hospital Readmission and Severe Lupus Disease Activity
Life with lupus can feel like a revolving door -- between your home, your rheumatologist's office, and the hospital. There are many costs associated with hospital readmission, including lost time and risk of catching a disease. So, how can Lupus Warriors and hospitals work together to avoid...
New Lab Test Identifies Lupus Flare Risk 12 Weeks in Advance
New blood test, aiSLE™ DX Flare Risk Index, identifies lupus flare risk up to 12 weeks in advance. The lab test is now available for clinical use. Note: Progentec Diagnostics, Inc., the company that developed aiSLE™ DX Flare Risk Index, also powers LupusCornerLife with lupus comes...
Coronavirus and Lupus | Things to Know
Coronavirus, also known as COVID-19, is a respiratory disease related to the common cold. Although most healthy people do not need to worry about the disease, people with lupus should be careful. This disease has been in the news lately, and COVID-19 (short for Coronavirus disease 2019) may well be...